Cargando…
Development of a model‐based clinical trial simulation platform to optimize the design of clinical trials for Duchenne muscular dystrophy
Early clinical trials of therapies to treat Duchenne muscular dystrophy (DMD), a fatal genetic X‐linked pediatric disease, have been designed based on the limited understanding of natural disease progression and variability in clinical measures over different stages of the continuum of the disease....
Autores principales: | Lingineni, Karthik, Aggarwal, Varun, Morales, Juan Francisco, Conrado, Daniela J., Corey, Diane, Vong, Camille, Burton, Jackson, Larkindale, Jane, Romero, Klaus, Schmidt, Stephan, Kim, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923721/ https://www.ncbi.nlm.nih.gov/pubmed/34877803 http://dx.doi.org/10.1002/psp4.12753 |
Ejemplares similares
-
Multivariate modeling of magnetic resonance biomarkers and clinical outcome measures for Duchenne muscular dystrophy clinical trials
por: Kim, Sarah, et al.
Publicado: (2023) -
Standardized Data Structures in Rare Diseases: CDISC User Guides for Duchenne Muscular Dystrophy and Huntington’s Disease
por: Mullin, Ariana P., et al.
Publicado: (2020) -
Improving clinical trial design for Duchenne muscular dystrophy
por: Merlini, Luciano, et al.
Publicado: (2015) -
Microdystrophin Expression as a Surrogate Endpoint for Duchenne Muscular Dystrophy Clinical Trials
por: Chamberlain, Jeffrey S., et al.
Publicado: (2023) -
The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials
por: Ricotti, Valeria, et al.
Publicado: (2016)